La Hulpe / Groningen / Minneapolis / Roosendaal / Leusden / Milano / TWEAK / Amsterdam / Melbourne / San Diego / Lincoln / San Jose / St. Louis / Santa Cruz / /
Netherlands / Italy / Belgium / United States / Australia / United Kingdom / /
Currency
pence / / /
Event
Business Partnership / Product Issues / FDA Phase / /
Facility
Institute of Cellular Medicine / SuperKiller TRAIL / Newcastle University / Myeloma Center / TRAF2 complex / University of Amsterdam / Eliza Hall Institute / La Trobe University / C FasL TRAIL / Academic Medical Center / /
IndustryTerm
treatment of cancer / /
MedicalCondition
lung carcinoma / CD40-activated chronic lymphocytic leukemia / lymphocytic leukemia / Cancer Chronic / JE / chronic lymphocytic leukemia / tumor necrosis factor alpha / rather unique rhabdomyosarcoma cell line / melanoma / Ferrarini M. Chronic lymphocytic leukemia / RIPK3-dependent necrosis / Breast Cancer / render cancers / tumor necrosis factor-a / Lesslauer W. Human tumor necrosis / cancers / Leukemia / tumor / colon carcinoma / cancer / Disease / inflammatory breast cancer / J. Cancer / human cancer / B-cell chronic lymphocytic leukaemia cells / B-cell chronic lymphocytic leukemia / tumor necrosis / carcinomas / tumour necrosis factor / B-cell lymphoma / common leukemia / /
MedicalTreatment
chemotherapy / /
Organization
Dutch Cancer Society / TNF-family / TNFfamily / ND UM UM / ND ND / Lymphoma and Myeloma Center Amsterdam / AMC Ethical Review Board / Institute of Cellular Medicine / CLB Sanquin Blood Foundation / African Union / Eliza Hall Institute / Department of Experimental Immunology / La Trobe University / Melbourne / University of Amsterdam / Amsterdam / Academic Medical Center / Department of Experimental Oncology / Newcastle University / Newcastle upon Tyne / Department of Hematology / /
Person
Wang X. Overcoming / Alexis Biochemicals / Minna J et al. Autocrine / / /
Position
Shu HB / Hunter / representative / The Netherlands *Corresponding author / /